Big Pharma Could Take Notice of Nuvilex Inc. BALTIMORE,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Big Pharma Could Take Notice of Nuvilex Inc.

BALTIMORE, MD--(Marketwired - May 16, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, posits that given its current stage of clinical development it is possible that Nuvilex Inc. ( OTCQB : NVLX ) may eventually attract the interest of large pharmaceutical firms seeking to gain access to its highly efficacious and proprietary technology platform. Nuvilex Inc. ( OTCQB : NVLX ) is an international firm with a live-cell encapsulation technology initially directed to treat pancreatic cancer along with the development and study of the use of medical marijuana for the treatment of oncology patients.

Any arrangement typically begins with a lengthy due diligence process with no guarantees that anything material arises from such due diligence. Still, it is not uncommon that the process results in some form of partnership or collaboration. These collaborations often contain an agreement to assist in funding future research and development, a royalty arrangement should development lead to regulatory approval, and occasionally lead to a direct investment in the targeted company itself.

While many companies enter Phase III clinical trials without a partner, this prospective event is relevant to companies like Nuvilex Inc. ( OTCQB : NVLX ) since it is not uncommon for collaborative relationships to be formalized ahead of a Phase III clinical trial.

Additional detail regarding the structure of biotechnology collaboration relationships as well as other articles and Nuvilex reports can be accessed or downloaded in their entirety by visiting www.goldmanresearch.com .

About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock research reports, daily stock market blogs, and popular investment newsletters. For more information, visit www.goldmanresearch.com .

A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com .

About Nuvilex, Inc. ( OTCQB : NVLX ): Nuvilex, Inc. has been a provider of all-natural products for many years, has expanded its company to increase its natural product based footprint through medical marijuana studies and is becoming an international biotechnology provider of live, therapeutically valuable, encapsulated cells and services for treatments, research and medicine. The Company's offerings will ultimately include cancer, diabetes and other clinical treatments using the company's natural product knowledge, product base, cell and gene therapy expertise, and live-cell encapsulation technology in addition to other new products currently under development. For more information visit: www.nuvilex.com .

Goldman Small Cap Research Rob Goldman Analyst 410-609-7100 rob@goldmanresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 221

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

WellCare of Kentucky Partners with Owen County for Transit Grant

Updated Category News Views 139

WellCare of Kentucky Collaborates with Owen County for a Transportation Grant Improving transportation access for rural residents is essential to reducing barriers for medical visits and other important commitments. WellCare of Kentucky has announced a significant initiative that reflects this commitment by awarding Owen County Public Transit (OCPT) a grant worth $20,000....

Continue Reading
Domo Delivers Strong Growth in Q3 Fiscal 2025 Results

Updated Category News Views 117

Domo Reports Impressive Third Quarter Fiscal 2025 Results Domo, Inc. (Nasdaq: DOMO) has recently released its financial results for the fiscal third quarter, revealing significant growth and promising outlooks for the future. The company recorded a total revenue of $79.8 million, marking a strong performance driven by a $71.1 million subscription revenue component. The...

Continue Reading
Goodfellow Inc. Announces Q3 Earnings and Dividend Update

Updated Category News Views 73

Goodfellow Inc. Declares Q3 Financial Results and Dividend Goodfellow Inc. (TSX: GDL), a prominent name in the wood manufacturing and distribution sector, has recently shared its financial performance for the third quarter. Reporting net earnings of $5.8 million, or $0.68 per share, the figures show a slight decline from last year when net earnings reached $6.2 million at...

Continue Reading
Engagement and Health Awareness at ¡Vive Tu Vida! Event

Updated Category News Views 176

Engagement and Health Awareness at ¡Vive Tu Vida! Event The Mexican American Opportunity Foundation (MAOF) is set to host a spectacular health and wellness fair known as ¡Vive tu vida! Get Up! Get Moving!, where families will gather to celebrate health and promote physical activity. This much-anticipated event underscores the importance of community involvement in...

Continue Reading
Orca Scan Unveils Innovative Tool for Effortless Barcode Design

Updated Category News Views 105

Revolutionizing Barcode Generation with Orca Scan Creating barcodes has now become more accessible thanks to Orca Scan, a dynamic player in the software industry. The company recently unveiled an innovative barcode label designer aimed at streamlining the barcode creation process for users worldwide. This new tool provides enhanced functionality for businesses seeking...

Continue Reading